Lightning up
the vaccine discovery process

We help companies optimise their vaccines’ antigenicity and immunogenicity by analysing millions of genomes of viruses and immunological and epidemiological data.

Understand the behaviour of the virus

Get insights into the evolution of the epidemic

Meet the Founders

We started Deepflare with the goal of analysing genomes of SARS-CoV-2 and helping to develop. To achieve that, we developed an AI platform that analyses millions of viruses, predicts future variants, and quickly finds sequences to contain in a drug and vaccine.
More about our story
dark arrow

Schedule Meeting

Learn more about all the potential that our product can provide to enhance your business.